Methyl thiazolidine-4-carboxylate

Catalog No. :
ACKCCN658
CAS No. :
60667-24-5
Molecular Formula :
C5H9NO2S
Molecular Weight :
147.20

IUPAC Name:methyl thiazolidine-4-carboxylate

Methyl thiazolidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$71.00Login to see priceIn stockInquiry
250mg97%$127.00Login to see priceIn stockInquiry
1g97%$340.00Login to see priceIn stockInquiry
5g97%$1189.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl thiazolidine-4-carboxylate
IUPAC Namemethyl thiazolidine-4-carboxylate
MDL No.MFCD02737719
Molecular FormulaC5H9NO2S
Molecular Weight147.20
SMILESO=C(C1NCSC1)OC
InChI KeyNHBNAVLHRAPNKY-UHFFFAOYSA-N
Synonymmethyl thiazolidine-4-carboxylate;4-Thiazolidinecarboxylicacid,methylester(7CI,9CI);4-carbomethoxythiazoline;4-Thiazolidinecarboxylic acid methyl ester;Einecs 262-361-2;methyl 1,3-thiazolidine-4-carboxylate
CAS No.60667-24-5

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKCCN658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACKCCN658 route product structure diagram
    ACKCCN65860667-24-5 In Stock
Inquiry

2. ACKCCN658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKCCN658 route product structure diagram
    ACKCCN65860667-24-5 In Stock
Inquiry

Comments (0)